Suchergebnisse - "drug development"

PubPharm (9.303)

1

Evaluation of prompt engineering strategies for pharmacokinetic data analysis with the ChatGPT large language model

enthalten in: Journal of pharmacokinetics and pharmacodynamics | 2024

von Shin, E. | Ramanathan, M.

2

Biomarker-guided drug development provides value for patients, payers and drug developers : lessons learned from 25 years in the biomarker industry

enthalten in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2024

von Reese-Petersen, A. | Breisnes, H. | Gabor, D. | +7

3

Safety, tolerability and toxicokinetics of the novel mitochondrial drug SUL-138 administered orally to rat and minipig

enthalten in: Toxicology reports | 2024

von Swart, D. | de Haan, M. | Stevens, J. | +6

4

Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease

enthalten in: Journal of Alzheimer's disease : JAD | 2024

von Elghanam, Y. | Purja, S. | Kim, E.

5

Digital Health Technology (DHT) in European Clinical Trials, How to Improve the Status-Quo of the Regulatory Landscape?

enthalten in: Therapeutic innovation & regulatory science | 2024

von Podhaisky, H.

6

Evaluation of ChatGPT and Gemini large language models for pharmacometrics with NONMEM

enthalten in: Journal of pharmacokinetics and pharmacodynamics | 2024

von Shin, E. | Yu, Y. | Bies, R. | +1

7

Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target-Mediated Drug Disposition Model

enthalten in: Journal of clinical pharmacology | 2024

von Yuan, X. | An, G.

8

Factors Associated with Inclusion of Japan in Phase I Multiregional Clinical Trials in Oncology

enthalten in: Therapeutic innovation & regulatory science | 2024

von Maki, A. | Narukawa, M.

9

The increasing costs of medicines and their implications for patients, physicians and the health system

enthalten in: Internal medicine journal | 2024

von Ghinea, N.

10

Partial Orphan Cancer Drugs : US Food and Drug Administration Approval, Clinical Benefit, Trials, Epidemiology, Price, Beneficiaries, and Spending

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Michaeli, T. | Michaeli, D.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[931]